Cytosorbents Ownership | Who Owns Cytosorbents?


OverviewForecastRevenueFinancialsChartTranscripts

Cytosorbents Ownership Summary


Cytosorbents is owned by 24.36% institutional investors, 14.85% insiders, and 60.79% retail investors. Avenir is the largest institutional shareholder, holding 8.38% of CTSO shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.08% of its assets in Cytosorbents shares.

CTSO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCytosorbents24.36%14.85%60.79%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryMedical Device Stocks35.88%10.92%53.20%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Avenir5.22M8.38%$2.95M
Vanguard group2.20M3.51%$1.41M
Skylands capital1.71M2.74%$966.96K
Neuberger berman group1.68M2.70%$950.78K
Cm management1.48M2.37%$836.14K
Blackrock funding, inc. /de782.99K1.26%$443.41K
Blackrock655.80K1.21%$461.03K
Geode capital management707.26K1.14%$400.62K
Sargent investment group549.90K0.88%$311.41K
Pathstone499.95K0.80%$283.12K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Cm management1.48M0.70%$836.14K
Avenir5.22M0.36%$2.95M
Skylands capital1.71M0.13%$966.96K
Sargent investment group549.90K0.04%$311.41K
Key client fiduciary advisors78.46K0.02%$44.43K
Seelaus asset management16.30K0.01%$9.23K
Nwf advisory services104.14K0.01%$58.97K
Two sigma securities15.74K0.00%$14.70K
Marathon capital management10.00K0.00%$5.66K
Pathstone499.95K0.00%$283.12K

Top Buyers

HolderShares% AssetsChange
Vanguard fiduciary trust313.86K-313.86K
Geode capital management707.26K-103.50K
Neuberger berman group1.68M0.00%57.37K
Ritholtz wealth management27.44K0.00%27.44K
Two sigma securities15.74K0.00%15.74K

Top Sellers

HolderShares% AssetsChange
Granahan investment management---358.42K
Gsa capital partners llp---148.37K
Skylands capital1.71M0.13%-147.02K
Citadel advisors10.80K--138.48K
Amh equity---82.80K

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust313.86K-313.86K$177.64K
Ritholtz wealth management27.44K0.00%27.44K$15.54K
Hrt financial lp14.11K-14.11K$7.00K
Vanguard global advisers13.87K-13.87K$7.85K
Marathon capital management10.00K0.00%10.00K$5.66K

Sold Out

HolderChange
Qube research-1.00
Allworth financial lp-37.00
Fmr-384.00
Lazard asset management-1.09K
New wave wealth advisors-1.63K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202638-25.49%15,158,722-10.11%243.37%15-34.78%9-10.00%
Dec 31, 202538-22.45%16,197,322-1.88%253.71%17-22.73%8-20.00%
Sep 30, 2025489.09%16,334,989-0.63%263.78%22100.00%10-44.44%
Jun 30, 202542-14.29%16,329,093-3.59%263.35%11-52.17%1880.00%
Mar 31, 20252-96.08%381,533-97.51%-0.09%1-95.83%1-90.91%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.30M2.08%-
Vanguard Total Stock Mkt Idx Inv1.27M2.03%-
M&G (ACS) Granahan US Sm Cp Gr GBPZ1AAcc763.50K1.40%-101.78K
Neuberger Berman Intrinsic Value I674.87K1.08%-
Neuberger Intrinsic Value I647.01K1.03%-
Vanguard Institutional Extnd Mkt Idx Tr576.77K0.92%36.38K
Fidelity Extended Market Index390.14K0.62%94.21K
iShares Micro-Cap ETF146.44K0.23%-
JNL Multi-Manager Small Cap Growth A124.74K0.20%-310.82K
BlackRock Extended Equity Market K103.38K0.19%-44.00

Recent Insider Transactions


DateNameRoleActivityValue
Dec 13, 2024MARIANI PETER J Chief Financial OfficerBuy$19.29K
Dec 12, 2024MARIANI PETER J Chief Financial OfficerBuy$17.87K
Dec 11, 2024MARIANI PETER J Chief Financial OfficerBuy$10.10K
Dec 13, 2023Sobel Alan D.-Buy$30.00K
Dec 13, 2023Sobel Alan D.-Buy$15.79K

Insider Transactions Trends


DateBuySell
2025 Q4--
2025 Q3--
2025 Q1--
2024 Q43-
2024 Q3--

CTSO Ownership FAQ


Who Owns Cytosorbents?

Cytosorbents shareholders are primarily institutional investors at 24.36%, followed by 14.85% insiders and 60.79% retail investors. The average institutional ownership in Cytosorbents's industry, Medical Device Stocks, is 35.88%, which Cytosorbents falls below.

Who owns the most shares of Cytosorbents?

Cytosorbents’s largest shareholders are Avenir (5.22M shares, 8.38%), Vanguard group (2.2M shares, 3.51%), and Skylands capital (1.71M shares, 2.74%). Together, they hold 14.64% of Cytosorbents’s total shares outstanding.

Does Blackrock own Cytosorbents?

Yes, BlackRock owns 1.21% of Cytosorbents, totaling 655.8K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 461.03K$. In the last quarter, BlackRock decreased its holdings by -66.63K shares, a -9.22% change.

Who is Cytosorbents’s biggest shareholder by percentage of total assets invested?

Cm management is Cytosorbents’s biggest shareholder by percentage of total assets invested, with 0.70% of its assets in 1.48M Cytosorbents shares, valued at 836.14K$.

Who is the top mutual fund holder of Cytosorbents shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Cytosorbents shares, with 2.08% of its total shares outstanding invested in 1.3M Cytosorbents shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools